Belimumab for Treatment of cGVHD Following Allo-HCT
Clinical trial NCT05604742 · WITHDRAWN
Trial details
- NCT number
- NCT05604742
- Sponsor
- xuna
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-12-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.